Post-approval studies (Phase 4)Ended earlyNCT04973007
What this trial is testing
Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases
Who this might be right for
Oligometastatic DiseaseLiver MetastasesColorectal Cancer
University of Colorado, Denver 10